验证数据展示
经过测试的应用
Positive WB detected in | MCF-7 cells, T-47D cells, A549 cells, MKN-45 cells, NCI-H1299 cells |
推荐稀释比
应用 | 推荐稀释比 |
---|---|
Western Blot (WB) | WB : 1:500-1:3000 |
It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
Sample-dependent, Check data in validation data gallery. |
产品信息
29489-1-AP targets PKMYT1 in WB, ELISA applications and shows reactivity with Human samples.
经测试应用 | WB, ELISA Application Description |
经测试反应性 | Human |
免疫原 | PKMYT1 fusion protein Ag30573 种属同源性预测 |
宿主/亚型 | Rabbit / IgG |
抗体类别 | Polyclonal |
产品类型 | Antibody |
全称 | protein kinase, membrane associated tyrosine/threonine 1 |
别名 | DKFZp547K1610, FLJ20093, MYT1, Myt1 kinase, PKMYT1 |
计算分子量 | 55 kDa |
观测分子量 | 60-75 kDa |
GenBank蛋白编号 | NM_004203 |
基因名称 | PKMYT1 |
Gene ID (NCBI) | 9088 |
RRID | AB_3086137 |
偶联类型 | Unconjugated |
形式 | Liquid |
纯化方式 | Antigen affinity purification |
UNIPROT ID | Q99640 |
储存缓冲液 | PBS with 0.02% sodium azide and 50% glycerol , pH 7.3 |
储存条件 | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. |
背景介绍
PKMYT1, also known as MYT1, belongs to the WEE1 family. PKMYT1 functions to negatively regulate the Cdc2-cyclin B complexes by phosphorylating Cdc2 on threonine 14 and tyrosine 15. PKMYT1 has also been implicated in an increasing number of cancer types, including gastric cancer, non-small-cell lung cancer, hepatocellular carcinoma, glioblastoma, neuroblastoma, and colorectal cancer, in which overexpression of PKMYT1 generally correlates with poor prognosis and disease progression. PKMYT1 also has another key role in the cell cycle - regulating Golgi membrane reassembly following mitosis - and depletion of PKMYT1 leads to cell death. PKMYT1 was strongly phosphorylated during mitosis. This antibody can recognize interphase and mitotic phase PKMYT1. (PMID: 9268380, 32127662)
实验方案
Product Specific Protocols | |
---|---|
WB protocol for PKMYT1 antibody 29489-1-AP | Download protocol |
Standard Protocols | |
---|---|
Click here to view our Standard Protocols |